News and Trends 4 Oct 2019ADC Therapeutics Cancels Nasdaq IPO Amidst Market Growth Fears The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO, citing adverse market conditions caused… October 4, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 22 Mar 2017Swedish Oncology Biotech Teams up with World Leading Cancer Center The Swedish biotech Aprea Therapeutics has entered a new collaboration with the Memorial Sloan Kettering Cancer Center to study the… March 22, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 26 Dec 2016The Largest Deals, Fundraising and Exits of 2016 in European Biotech Curious about which technologies have attracted the most cash in biotech finance this year? Here's a list of the most impressive cash… December 26, 2016 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 12 Oct 2016Will Aprea live up to the Hype of its €46M fundraising? Aprea raised a huge €46M for a first-in-class drug that targets the deadliest form of ovarian cancer. The company just started Phase II… October 12, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jun 201612 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting Pharma and Biotech from every corner flocked to Chicago for the beginning of June. Why? It's where one of the… June 8, 2016 - 7 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 4 Apr 2016Biotech Environment in 2016: Reverse Engineering the Ecosystem #BES2016 BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference was about partnering, trends and… April 4, 2016 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2016The Largest Scandinavian Biotech Fundraising of 2016 has just been Signed Aprea (Sweden) is not a well-know Biotech (yet), but has succeeded in raising €46M from big investors in the US… March 10, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email